Berkshire's significant share buybacks and large-scale acquisitions in Q1

```htmlGolden Ten Data May 2｜Berkshire Hathaway disclosed major financial and capital operation data for the first quarter of 2026. The company spent $235 million to repurchase its own shares during the period, adhering to intrinsic value as the standard and decisively executing buybacks when valuations are favorable, considering it as the optimal financial choice. On the balance sheet side, holdings of cash and Treasury bills nearly reached $38 billion, and the sum of cash and overall investments totaled $70.58 billion, demonstrating robust cash flow generation capabilities, with operating cash flow for the single quarter approaching $15 billion. Capital operations were frequent, completing the Oxy transaction using $950 million in float, acquiring Bell Lab, a rodenticide company, implementing the vision that Charlie Munger had laid out during his lifetime. Although some transactions temporarily dragged down short-term performance, the long-term strategic value is highlighted, with abundant overall cash reserves and ample space for further capital operations.```